NanoViricides Statistics

Total Valuation

NanoViricides has a market cap or net worth of $21.03 million. The enterprise value is $17.77 million.

Market Cap	21.03M
Enterprise Value	17.77M

Important Dates

The last earnings date was Wednesday, May 15, 2024, before market open.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

NanoViricides has 11.81 million shares outstanding. The number of shares has increased by 1.23% in one year.

Shares Outstanding	11.81M
Shares Change (YoY)	+1.23%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	4.60%
Owned by Institutions (%)	10.10%
Float	11.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.97
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.32, with zero debt.

Current Ratio	4.32
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-189.90

Financial Efficiency

Return on equity (ROE) is -74.70% and return on invested capital (ROIC) is -92.02%.

Return on Equity (ROE)	-74.70%
Return on Assets (ROA)	-66.50%
Return on Capital (ROIC)	-92.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.36M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +53.45% in the last 52 weeks. The beta is 0.94, so NanoViricides's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+53.45%
50-Day Moving Average	1.94
200-Day Moving Average	1.37
Relative Strength Index (RSI)	44.15
Average Volume (20 Days)	446,784

Short Selling Information

The latest short interest is 237,328, so 2.01% of the outstanding shares have been sold short.

Short Interest	237,328
Short Previous Month	126,429
Short % of Shares Out	2.01%
Short % of Float	2.11%
Short Ratio (days to cover)	0.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.80M
Pretax Income	-9.51M
Net Income	-9.51M
EBITDA	-8.70M
EBIT	-9.46M
Earnings Per Share (EPS)	-$0.82

Full Income Statement

Balance Sheet

The company has $3.26 million in cash and no debt, giving a net cash position of $3.26 million or $0.28 per share.

Cash & Cash Equivalents	3.26M
Total Debt	n/a
Net Cash	3.26M
Net Cash Per Share	$0.28
Equity (Book Value)	10.65M
Book Value Per Share	0.90
Working Capital	2.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.33 million and capital expenditures -$60,963, giving a free cash flow of -$6.39 million.

Operating Cash Flow	-6.33M
Capital Expenditures	-60,963
Free Cash Flow	-6.39M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NanoViricides does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.23%
Shareholder Yield	-1.23%
Earnings Yield	-45.21%
FCF Yield	-30.40%

Analyst Forecast

The average price target for NanoViricides is $6.50, which is 265.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	265.17%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 24, 2019. It was a reverse split with a ratio of 1:20.

Last Split Date	Sep 24, 2019
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1